Snehal Shah

Teknisk/Vetenskaplig/F&U Direktör på OCULIS HOLDING AG

Commercial Services

Consumer Services

Health Technology

Profil

Snehal Shah currently works at Oculis Holding AG, as President-Research & Development from 2024.
Dr. Shah also formerly worked at Noven Pharmaceuticals, Inc., as Member-Hisamitsu Group from 2012 to 2017, Kyowa Kirin Co., Ltd., as Senior Vice President-Regulatory Affairs from 2017 to 2021, and IVERIC bio, Inc., as SVP, Chief Regulatory & Product Strategy Officer.
Dr. Shah received his doctorate degree from the University of Kansas and undergraduate degree from Rutgers University- Newark.

Aktiva positioner av Snehal Shah

Företag	Position	Start
OCULIS HOLDING AG	Teknisk/Vetenskaplig/F&U Direktör	2024-04-10

Alla aktiva positioner av Snehal Shah

Tidigare kända positioner av Snehal Shah

Företag	Position	Slut
KYOWA KIRIN CO., LTD.	Generell Rådgivare	2021-01-01
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products	Företagsledare/Principal	2017-01-01
IVERIC BIO, INC.	Generell Rådgivare	-

Se detaljerna i Snehal Shahs erfarenhet

Snehal Shahs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Snehal Shahs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products	Commercial Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IVERIC bio, Inc. IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases	Health Technology
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Rutgers University- Newark Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oculis Holding AG Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases	Commercial Services